Identification of 4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline derivatives as a new class of orally and selective Polo-like kinase 1 inhibitors
about
PLK-1 Targeted Inhibitors and Their Potential against TumorigenesisPlk1-targeted small molecule inhibitors: molecular basis for their potency and specificity.Combined pharmacophore modeling, docking, and 3D-QSAR studies of PLK1 inhibitors.Combined Inhibition of MEK and Plk1 Has Synergistic Antitumor Activity in NRAS Mutant Melanoma.Validation of Polo-like kinase 1 as a therapeutic target in pancreatic cancer cellsPolo-like kinase 1 inhibitors in mono- and combination therapies: a new strategy for treating malignancies.Quinazoline derivatives as potential anticancer agents: a patent review (2007 - 2010).Spotlight on Volasertib: Preclinical and Clinical Evaluation of a Promising Plk1 Inhibitor.Plk1 Inhibitors in Cancer Therapy: From Laboratory to Clinics.Molecular modeling studies of 4,5-dihydro-1H-pyrazolo[4,3-h] quinazoline derivatives as potent CDK2/Cyclin a inhibitors using 3D-QSAR and docking.A novel catalytic process for trifluoromethylation of bromoaromatic compounds.Monitoring and inhibition of Plk1: amphiphilic porphyrin conjugated Plk1 specific peptides for its imaging and anti-tumor function.Molecular interactions of c-ABL mutants in complex with imatinib/nilotinib: a computational study using linear interaction energy (LIE) calculations.
P2860
Q26777811-9946E01C-1555-404E-90D6-45559DE09BF5Q33978551-6036EE5E-A6AB-41AD-891C-ED4361C9365FQ35669467-A6911D7F-F8EB-4ED2-8623-FD6892541CEEQ36054290-CF494635-8CCA-4106-A243-424BB85B80E8Q36312159-FF5B7C19-CAAA-410F-96F6-74C7478CBA0AQ37909373-684C9220-55A3-4B18-8BF5-B6BACA96694EQ37992086-60A1E24D-4C24-4FB8-8D4B-FE7000D39D36Q38824242-06C520AA-845B-4BD4-9DC5-5EE2F05949BDQ38872725-8AF93B30-7AEB-4BA2-8354-157126F2ED0FQ41239527-795C91EA-B873-42E0-9289-2A22EDE955C8Q46854076-D71F74E0-9038-4D2A-9C5D-DEA3724DB088Q54341332-2793C51A-2016-45EA-8390-7024F9B15108Q54512250-F5CFE645-8DC8-43CF-9AF4-DDC10D818B95
P2860
Identification of 4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline derivatives as a new class of orally and selective Polo-like kinase 1 inhibitors
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Identification of 4,5-dihydro- ...... Polo-like kinase 1 inhibitors
@ast
Identification of 4,5-dihydro- ...... Polo-like kinase 1 inhibitors
@en
Identification of 4,5-dihydro- ...... Polo-like kinase 1 inhibitors
@nl
type
label
Identification of 4,5-dihydro- ...... Polo-like kinase 1 inhibitors
@ast
Identification of 4,5-dihydro- ...... Polo-like kinase 1 inhibitors
@en
Identification of 4,5-dihydro- ...... Polo-like kinase 1 inhibitors
@nl
prefLabel
Identification of 4,5-dihydro- ...... Polo-like kinase 1 inhibitors
@ast
Identification of 4,5-dihydro- ...... Polo-like kinase 1 inhibitors
@en
Identification of 4,5-dihydro- ...... Polo-like kinase 1 inhibitors
@nl
P2093
P50
P356
P1476
Identification of 4,5-dihydro- ...... Polo-like kinase 1 inhibitors
@en
P2093
Anna De Ponti
Antonella Ciavolella
Barbara Valsasina
Daniela Borghi
Daniele Volpi
Dario Ballinari
Enrico Pesenti
Gabriele Fachin
Helena Posteri
Italo Beria
P304
P356
10.1021/JM901713N
P407
P577
2010-05-13T00:00:00Z